NitroimidazolesMisonidazoleRadiation-Sensitizing AgentsCell HypoxiaAntineoplastic AgentsEtanidazoleRadiation DosageRadiation, IonizingCell SurvivalRadiation ToleranceCell Line, TumorDose-Response Relationship, RadiationRadiation InjuriesDrug Resistance, NeoplasmDrug ResistanceNeoplasmsApoptosisOxygenAnoxiaDrug Screening Assays, AntitumorTumor Cells, CulturedTriazinesRadiationDoxorubicinRadiation ProtectionRadiation MonitoringHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor 1Cell LineNitrofuransSarcoma, ExperimentalNeoplasms, ExperimentalCricetulusDNA DamageCisplatinMice, NudePorfiromycinCricetinaeAntineoplastic Agents, PhytogenicDose-Response Relationship, DrugNimorazoleXenograft Model Antitumor AssaysCell ProliferationAntibiotics, AntineoplasticLeukemia P388Neoplasm TransplantationCell DivisionDrug Resistance, MultipleDrug SynergismCell CycleRadiation OncologyTime FactorsMice, Inbred C3HGene Expression Regulation, NeoplasticMitomycinsCells, CulturedSignal TransductionP-GlycoproteinTransfectionFlow CytometryMitomycinCell DeathGamma RaysDrug Delivery SystemsCombined Modality TherapyCosmic RadiationRNA, MessengerRadiation Injuries, ExperimentalEtoposideProdrugsMammary Neoplasms, ExperimentalMutationBlotting, WesternDNAPaclitaxelDrug Carriers5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazoleTransplantation, HeterologousRadiation PneumonitisMice, Inbred BALB CColonic NeoplasmsFibrosarcomaEnediynesLeukemia L1210DNA-Binding ProteinsNitrofurazoneNeoplasms, Radiation-InducedDNA Topoisomerases, Type IIBreast NeoplasmsKineticsEllipticinesCaspasesDown-RegulationHCT116 CellsHeLa CellsRadiotherapyUltraviolet RaysBackground RadiationEnzyme InhibitorsTumor Suppressor Protein p53